Skip to main content

Table 1 Clinical characteristics of the patients

From: The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery

 

all

BMI < 37.5

BMI ≥ 37.5

P value

n

90

37

53

/

Male [n(%)]

43 (47.8)

15 (40.5)

28 (52.8)

0.251

Age (years)

30.58 ± 9.48

31.78 ± 9.78

29.74 ± 9.26

0.316

Waist (cm)

119.98 ± 15.23

106.95 ± 11.23

128.56 ± 10.79

< 0.001

ALT (U/L)

58.94 ± 50.80

57.56 ± 55.43

59.90 ± 47.83

0.831

AST (U/L)

32.70 ± 23.72

29.82 ± 20.66

34.71 ± 25.63

0.339

γGT (U/L)

48.99 ± 39.28

40.35 ± 22.18

54.40 ± 46.34

0.113

Glucose (mmol/L)

5.97 ± 1.94

6.18 ± 2.21

5.82 ± 1.73

0.405

HbA1c (%)

6.78 ± 1.87

6.76 ± 2.09

6.80 ± 1.72

0.919

TG (mmol/L)

1.91 ± 1.08

2.03 ± 0.98

1.83 ± 1.15

0.400

TC (mmol/L)

4.60 ± 0.80

4.61 ± 0.86

4.59 ± 0.77

0.899

LCN2 (ng/mL)

103.81 ± 45.26

92.68 ± 32.68

111.59 ± 51.16

0.035

CAP (dB/m)

352.40 ± 45.88

340.78 ± 45.02

360.51 ± 45.14

0.044

  1. Results are shown as mean ± SD or number (percentage)
  2. BMI: body mass index; ALT: alanine aminotransferase; AST: aspartate aminotransferase; γGT: glutamyltransferase; TG: triglyceride; TC: total cholesterol; CAP: controlled attenuation parameter